Connections between rheumatology and oncology – discussions based on a case report
Tumor necrosis factor (TNF) inhibitors are commonly utilized medications for the treatment of immune mediated conditions. Based on recent data from most registries there is no conclusive evidence for an increased risk of solid tumours or lymphoproliferative disease linked with biologic therapy, but...
Main Authors: | Laura Groseanu, Mihaela Lebedenco, Anca Ursu, Carmen Petcu, Ruxandra Ionescu |
---|---|
Format: | Article |
Language: | English |
Published: |
Amaltea Medical Publishing House
2019-12-01
|
Series: | Romanian Journal of Rheumatology |
Subjects: | |
Online Access: | https://rjr.com.ro/articles/2019.4/RJR_2019_4_Art-06.pdf |
Similar Items
-
Lymphoma developing in a patient with long-term antitumor necrosis factor therapy
by: Giovana Serrão Fensterseifer, et al.
Published: (2022-07-01) -
Investigating the genetics and immunopathogenesis of ankylosing spondylitis
by: Liu, F
Published: (2024) -
Prospective study of patients with inflammatory back pain, clinical characteristics and treatment response in ankylosing spondylitis in two centers of rheumatology in South India
by: Subramanian Nallasivan, et al.
Published: (2022-01-01) -
THE DIAGNOSIS AND CLINICAL CHARACTERISTICS OF ANKYLOSING SPONDYLITIS ACCORDING TO THE DATA OF THE KAZAN CITY RHEUMATOLOGY CENTER
by: L I Myasoutova, et al.
Published: (2012-02-01) -
Hepatitis B reactivation and current clinical impact Reactivación de la hepatitis B y su impacto clínico actual
by: B. Álvarez Suárez, et al.
Published: (2010-09-01)